Related Experiment Video
Updated: Oct 23, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Ventricular pacing and myocardial function in patient with congenital heart block
Gautam Rangavajla1, Suresh Mulukutla2, Floyd Thoma2
1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Insights
Right ventricular pacing increases cardiomyopathy risk in congenital heart block patients. This study confirms RV pacing
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Pacing-induced cardiomyopathy (PICM) is a known risk of chronic right ventricular (RV) pacing.
- Characterizing PICM is challenging in adults due to pre-existing cardiomyopathies.
- Congenital heart block (cHB) offers a unique model to study PICM without confounding factors.
Purpose of the Study:
- To investigate the incidence of PICM in patients with congenital heart block (cHB).
- To assess the impact of RV pacing on myocardial function in a cHB cohort.
- To evaluate the long-term effects of pacing on left ventricular ejection fraction (LVEF) in cHB patients.
Main Methods:
- Retrospective cohort analysis of 42 cHB patients with preserved baseline LVEF (≥50%).
- Kaplan-Meier analysis to compare cardiomyopathy development (LVEF <50%) between paced and non-paced groups.
- Median follow-up of 35 years from birth.
Main Results:
- Patients receiving a pacemaker (PM) were significantly more likely to develop cardiomyopathy (p=0.021).
- No cardiomyopathy developed in non-paced patients.
- Biventricular pacing improved LVEF in four patients who developed cardiomyopathy.
Conclusions:
- In a young, healthy cHB cohort, RV pacing is associated with an increased risk of cardiomyopathy.
- These findings confirm the detrimental effects of RV pacing on myocardial function in patients without prior cardiac disease.
- Clinical management of cHB patients should consider the risks of RV pacing.
Introduction:
Pacing-induced cardiomyopathy (PICM) is a potential complication of chronic right ventricular (RV) pacing, but its characterization in adult patients is often complicated by pre-existing cardiomyopathy. This study investigated the incidence of PICM in patients with congenital heart block (cHB) who have conduction disease from birth without confounding pre-existing cardiac conditions.
Methods And Results:
This retrospective cohort analysis included 42 patients with cHB and baseline left ventricular ejection fraction (LVEF) ≥50%. Kaplan-Meier analysis was used to assess freedom from cardiomyopathy (defined as LVEF <50%) between paced and nonpaced patients. Patients were 26 ± 3 years old at first presentation, 64% were women and baseline LVEF was 60.0 ± 0.2%. Median follow-up from birth was 35 (interquartile range [IQR]: 20-42) years with a median of 6.7 years (IQR: 3.6-9.2) at our institution. Thirty-two patients received pacing at mean age 21 ± 3 years. Patients receiving a pacemaker (PM) were significantly more likely to develop a cardiomyopathy (p = .021) and no patient developed a cardiomyopathy in the absence of a PM. Four patients who developed a new cardiomyopathy were upgraded to biventricular pacing, leading to stabilization or improvement of LVEF.
Conclusion:
In a relatively young and healthy cHB cohort, RV pacing is associated with a higher risk of developing a cardiomyopathy. These data confirm the deleterious effects of RV pacing on myocardial function in patients without pre-existing structural cardiac disease and has clinical implications to the management of patients with cHB.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...